Tier 3 · Filer Universe
Lineage Cell Therapeutics, Inc.
LCTX · NYSE American · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$1.06
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0000876343
Liquidity rank
#4065
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $14.56M | 2025-12-31 | 0001193125-26-093992 |
| Annual diluted EPS | -0.28 | 2025-12-31 | 0001193125-26-093992 |
| Quarterly revenue | $1.07M | 2026-06-30 | 0001193125-26-338064 |
| Quarterly diluted EPS | -0.03 | 2026-06-30 | 0001193125-26-338064 |
SEC EDGAR Frames batch generated 2026-08-10T23:34:18.959Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNYSE AmericanDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames